Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited

Antonia L. Moore(University of Copenhagen), Andrew Phillips(Wake Forest University), Christine Katlama(Université Paris Cité), Ole Kirk(University of Copenhagen), Anders Blaxhult(The Royal Free Hospital), Robert Colebunders(University of Antwerp), Antonio Chiesi(Istituto Superiore di Sanità), Jens D. Lungren(University of Copenhagen), Manfred Dietrich(Bernhard Nocht Institute for Tropical Medicine)
JAIDS Journal of Acquired Immune Deficiency Syndromes
April 1, 2003
10.1097/00126334-200304010-00017
Cited by 142

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987